Skip to Content

Insights From Our Labs to Yours

Covance Blog

  • Home
  • Industry
    • Device
    • Drug
    • Chemical
    • Crop
  • Phase
    • Discovery
    • Preclinical/Nonclinical
    • Phase I-IIa
    • Phase IIb-III
    • Pilot
    • Pivotal
    • Formulation, Packaging, etc.
  • Molecule Type
    • Biologics
    • Small Molecules
    • Biosimilars
    • Biomarkers
    • Cell/Gene Therapies
  • Data/Informatics
    • SEND
    • Modeling
    • Patient Recruitment
    • Xcellerate
  • About Us
    • Careers and Culture
    • Contact Us
    • Covance.com

Uncategorized

Home / Uncategorized
Gene Therapies
Share

IND-Enabling programs for gene therapies

by Covance Inc.updated on Friday, October 9, 2020Friday, October 9, 2020

Gene therapies continue to hold promise as treatments for many diseases but there are numerous and unique challenges to developing them for submission as an Investigational New Drug (IND)/ Investigational Medicinal Product Dossier (IMPD) application for use in clinical trials. These applications require an optimized scientific program designed to address …

Share

We’ve got preferences and so do you

by Covance Inc.updated on Tuesday, June 2, 2020Monday, June 4, 2018

Is it possible for a global CRO to improve – and even reshape – today’s drug development industry? We think so. We work with people like you to offer unique perspectives at every stage of development – from early phase development to clinical trials and commercialization. But enough about us. …

Copyright © 2020 Covance Inc. All rights reserved.